U.K. Using AI To Tackle Deadly Diseases

Share post:

Britain’s artificial intelligence research laboratory, DeepMind Technologies, a subsidiary of Alphabet Inc, announced in a recent press release that it will use AI to fight the deadliest parasitic diseases in the developing world.

This will be done in partnership with the Drugs for Neglected Diseases Initiative (DNDI) to treat diseases such as Chagas and Leishmaniasis, which affect up to 23 million people worldwide.

The company also said it would focus on “underserved” and “neglected” areas.

Commenting on the latest development, Pushmeet Kohli, Head of DeepMind AI-for-Science, said: “We’ve been excited by the potential for this technology to help fill in some of the gaps in our understanding of biology and accelerate scientific research to enable new, effective treatments for diseases. We hope AlphaFold will have a real-world impact on our understanding of disease and drug discovery for communities who are in great need of treatments.”

For more information, read the original story in the BBC.

Featured Tech Jobs


Related articles

Canadian group gets $2.2 million to research AI threat detection for wireless networks

Ericsson Canada and three universities have been awarded funds by the National Cybersecurity

Proposed Canadian AI law ‘fundamentally flawed,’ Parliament told

A privacy lawyer said the proposed AI bill is vague and sets a dangerous precedent

Canada, U.S. sign international guidelines for safe AI development

Eighteen countries, including Canada, the U.S. and the U.K., today agreed on recommended guidelines to developers in their nations for the secure design, development, deployment, and operation of artificial intelligent systems. It’s the latest in a series of voluntary guardrails that nations are urging their public and private sectors to follow for overseeing AI in

Is OpenAI’s Q* Artificial General Intelligence?

OpenAI's latest model, Q* (pronounced Q Star), is raising eyebrows in the AI community as a potential milestone...

Become a member

New, Relevant Tech Stories. Our article selection is done by industry professionals. Our writers summarize them to give you the key takeaways